Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
10,781,082
-
Total 13F shares
-
1,083,678
-
Share change
-
+29,969
-
Total reported value
-
$5,233,851
-
Put/Call ratio
-
5.3%
-
Price per share
-
$4.83
-
Number of holders
-
21
-
Value change
-
+$124,192
-
Number of buys
-
9
-
Number of sells
-
10
Institutional Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q1 2023
As of 31 Mar 2023,
Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,083,678 shares.
The largest 10 holders included
VANGUARD GROUP INC, NewEdge Advisors, LLC, CARLSON CAPITAL L P, CM Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, Redmond Asset Management, LLC, HORIZON KINETICS ASSET MANAGEMENT LLC, STATE STREET CORP, UBS Group AG, and Bank of New York Mellon Corp.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.